KCNMA1 and diabetes mellitus: In addition, the knockout of AKAP 150 (murine AKAP150, a homolog of human AKAP79) was reported to ameliorate vascular dysfunction in diabetes by improving BK channels through the Akt/GSK3β signaling pathway [43].